Free colonoscopies for people whose at-home stool tests (such as Cologuard and FIT) turn up signs of potential cancer are now covered by insurance, and a study shows this will save money.

A national study of blood ferritin and hemoglobin levels from tween, teen and young adult females suggests routine screening might be needed for iron deficiency and anemia

A 2011 FDA mandate to limit acetaminophen in combo opioid products led to a 13% y-o-y reduction in hospitalizations for serious liver injury.

A Michigan Medicine study may accelerate identifying patients who need liver transplants.

Direct-to-consumer home-based tests for infections, cancer, genetic traits and more are widely available but regulation, authorization or approval by FDA is not always clear.

Study shows members of public are most likely to want notification if commercial researchers may use identifiable health information – even more than for research on biospecimens.

A human genetics experts discusses how these DNA tests might be useful in practice and what cautions remain.

A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.

New technique visualizes all gene expression from a tissue.

A research team from Michigan Medicine has developed a new potential treatment for fatty liver disease in patients with partial lipodystrophy and/or NASH.

A pregnant liver transplant recipient receives cutting-edge monoclonal antibody treatment for COVID-19 months before her due date.

Research finds juvenile myositis and lupus share an inflammatory pathway, but their  pathophysiological differences may serve as diagnostic biomarkers in future studies.

A patient, a mother and their health care family.

A new potential biomarker raises concerns over the current standard for treating COVID-19 induced blood clots with high dose blood thinners.

People whose blood pressure is hard to control might have another condition that’s the real culprit. So why aren’t they being tested for primary aldosteronism?